Viewing nowCombinationJadimet Tablet 5/500 Milligrams (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.

MFDS item code 202201742 · Approved 2022.04.29 · Insurance code 644915060
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is developed to assist adult patients with type 2 diabetes in controlling their blood sugar levels in conjunction with dietary and exercise regimens. It is particularly effective for patients whose blood sugar levels are inadequately controlled, and caution should be observed according to expert guidelines in cases of confirmed cardiovascular diseases. This improves blood sugar control and aids in the overall health management of patients.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia. This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months. If renal function declines to a CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately. In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into account.
This medication is used for treating diabetes and helps lower blood sugar levels. However, caution must be taken as rare side effects such as severe lactic acidosis may occur when taking this medication. Lactic acidosis is a condition where lactic acid accumulates excessively in the body and can be very dangerous. Additionally, if taken with insulin or other diabetes medications, hypoglycemia may occur, so regular blood sugar monitoring is essential. Patients with severely impaired kidney function, acute renal issues, severe infections, heart failure, or acute myocardial infarction should not take this medication. Before and after examinations using iodine contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. It is also safest for pregnant or breastfeeding women to avoid using this medication. This medication may cause fluid loss, so caution is necessary in cases of dehydration, vomiting, or diarrhea, especially in elderly patients or those with cardiovascular diseases. During treatment, urinary or genital infections may occur, so any unusual symptoms should be promptly discussed with a healthcare provider. Vitamin B12 levels may decrease, so regular blood tests are recommended for long-term users. Alcohol consumption can increase the risk of side effects, so excessive drinking should be avoided while on this medication. If scheduled for surgery or experiencing serious illness, one should inform healthcare providers and temporarily discontinue this medication. Regular checks on blood sugar control status should be carried out while taking this medication, and immediate action should be taken in case of hypoglycemic symptoms. Lastly, this medication is not recommended for children or adolescents under 18 years old, and elderly patients should regularly check kidney function to maintain appropriate dosage levels.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture and kept at room temperature between 1 and 30 degrees Celsius. This will help maintain the efficacy of the medication for a longer period.
Orange-yellow, elliptical, biconvex, film-coated tablet
10 tablets/box [10 tablets/PTP×1], 60 tablets/box [10 tablets/PTP×6], 60 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.